4//SEC Filing
ENZON PHARMACEUTICALS INC 4
Accession 0001209191-08-034305
$ENZNCIK 0000727510operating
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:06 PM ET
Size
8.4 KB
Accession
0001209191-08-034305
Insider Transaction Report
Form 4
Geltosky John
Director
Transactions
- Award
Common Stock
2008-05-22$8.99/sh+8,343$75,004→ 8,343 total - Award
Stock Option (right to buy)
2008-05-22+22,930→ 22,930 totalExercise: $8.99Exp: 2018-05-22→ Common Stock (22,930 underlying)
Footnotes (4)
- [F1]Restricted stock units granted by Enzon Pharmaceuticals, Inc. ("Enzon") pursuant to Enzon's 2001 Incentive Stock Plan and qualified under Rule 16b-3(d).
- [F2]Of the 8,343 shares granted, 2,781 will vest on May 22, 2009, 2,781 will vest on May 22, 2010 and the remaining 2,781 will vest on May 22, 2011 so long as Mr. Geltosky is a member of the board of directors on the above dates.
- [F3]Stock option granted by Enzon pursuant to Enzon's 2001 Incentive Stock Plan and qualified under Rule 16b-3(d).
- [F4]Of the 22,930 options granted by Enzon, 7,644 will vest on May 22, 2009, 7,643 will vest on May 22, 2010 and the remaining 7,643 will vest on May 22, 2011 so long as Mr. Geltosky is a member of the board of directors on the above dates.
Documents
Issuer
ENZON PHARMACEUTICALS INC
CIK 0000727510
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000727510
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:06 PM ET
- Size
- 8.4 KB